Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Single-Cell DNA Sequencing for Novel Cancer and Precision Medicine Analysis

Precision Medicine
June 24, 2022

The inherent complexity of cancer provides investigators and clinicians with a challenging mix of cells in various states to fully understand disease biology and inform therapeutic decisions. Empowering cancer researchers to explore fundamental biological questions that were previously inconceivable is why the Tapestri from Mission Bio was designed. Quantitative characterization of genotype and phenotype at the single-cell level reveals clonal phylogeny and selection at higher resolution, which should ultimately enable better personalized therapeutic selection. Thus, by identifying SNVs, CNVs and surface protein expression changes in the same cellular background, Tapestri enables comprehensive insights into disease progression, development of resistance, and measurable residual disease (MRD).

For this Inside Precision Medicine webinar, our guest presenters, Dr. Todd Druley and Aaron Llanso will discuss applying single-cell DNA sequencing to MRD, clonal hematopoiesis (CHIP), solid tumor, and precision medicine. In addition, our presenters will describe how to track the clonal evolution of cancer with single-cell DNA sequencing and how to link genotype and phenotype with multi-omics—all while providing new translational applications for the clinic.

A live Q&A session will follow the presentations, offering you a chance to pose questions to our expert panelists.

8:00AM Pacific Daylight Time
Precision Medicine
Todd Druley, MD, PhD, Chief Medical Officer, Mission Bio; Aaron Llanso, Senior Director, Business Development, Mission Bio